Annovis Bio Statistics Share Statistics Annovis Bio has 19.49M
shares outstanding. The number of shares has increased by 41.23%
in one year.
Shares Outstanding 19.49M Shares Change (YoY) 41.23% Shares Change (QoQ) 0% Owned by Institutions (%) 9.09% Shares Floating 15.59M Failed to Deliver (FTD) Shares 1,475 FTD / Avg. Volume 0.57%
Short Selling Information The latest short interest is 1.59M, so 8.15% of the outstanding
shares have been sold short.
Short Interest 1.59M Short % of Shares Out 8.15% Short % of Float 9.51% Short Ratio (days to cover) 8.79
Valuation Ratios PE Ratio 0 Forward PE -1.86 PS Ratio 0 Forward PS 3.9 PB Ratio 6.58 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Annovis Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.59,
with a Debt / Equity ratio of 0.
Current Ratio 3.59 Quick Ratio 3.59 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -14.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.07B Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -73.72% in the
last 52 weeks. The beta is 1.62, so Annovis Bio's
price volatility has been higher than the market average.
Beta 1.62 52-Week Price Change -73.72% 50-Day Moving Average 2.44 200-Day Moving Average 2.63 Relative Strength Index (RSI) 46.5 Average Volume (20 Days) 256,952
Income Statement
Revenue n/a Gross Profit n/a Operating Income -26.7M Net Income -24.59B EBITDA -22.74M EBIT -22.74M Earnings Per Share (EPS) -2018.5
Full Income Statement Balance Sheet The company has 10.55M in cash and 0 in
debt, giving a net cash position of 10.55M.
Cash & Cash Equivalents 10.55M Total Debt n/a Net Cash n/a Retained Earnings -134.85M Total Assets 21.45B Working Capital 14.33B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.89B
and capital expenditures 0, giving a free cash flow of -21.89B.
Operating Cash Flow -21.89B Capital Expenditures n/a Free Cash Flow -21.89B FCF Per Share -1797.29
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
